DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Velcade (Bortezomib) - Pyrexia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pyrexia (110)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Velcade (Bortezomib) where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 110   Next >>

Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22

Patient: male, weighing 86.2 kg (189.6 pounds)

Reactions: Vomiting, Nausea, Hypotension, Systemic Inflammatory Response Syndrome, Pyrexia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in 69 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20

Patient: 69 year old female, weighing 71.8 kg (158.0 pounds)

Reactions: Pyrexia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Temsirolimus
    Dosage: 25 mg, weekly, iv
    Indication: Mantle Cell Lymphoma
    Start date: 2012-04-25
    End date: 2012-08-15

Velcade
    Dosage: 1.6 mq/m2, weekly, iv
    Indication: Mantle Cell Lymphoma
    Start date: 2012-04-25
    End date: 2012-08-15

Other drugs received by patient: Potassium Chloride; Hydrodiuril; Diovan; Acyclovir



Possible Velcade side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16

Patient: female, weighing 87.8 kg (193.2 pounds)

Reactions: Neuropathy Peripheral, Upper Respiratory Tract Infection, Urinary Tract Infection, Pleural Effusion, Pyrexia, Leukocytosis, Sinusitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Mantle Cell Lymphoma

Cytarabine
    Dosage: 1.87 g, cyclic
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: Mantle Cell Lymphoma

Doxorubicin Hydrochloride
    Dosage: 50 mg/m2, unk
    Indication: Mantle Cell Lymphoma

Mesna
    Dosage: 600 mg/m2, unk
    Indication: Mantle Cell Lymphoma

Methotrexate
    Indication: Mantle Cell Lymphoma

Rituximab
    Dosage: 1 mg/m2, cyclic
    Indication: Mantle Cell Lymphoma

Velcade
    Dosage: 0.7 mg/m2, cyclic
    Start date: 2012-03-19

Velcade
    Dosage: 2.77 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-12-31

Velcade
    Dosage: 0.7 mg/m2, cyclic

Velcade
    Dosage: 0.7 mg/m2, cyclic
    Start date: 2012-02-26

Vincristine
    Dosage: 2 mg, cyclic
    Indication: Mantle Cell Lymphoma

Other drugs received by patient: Sennosides A+B; Nystatin; Diphenhydramine Hydrochloride; Neupogen; Fluconazole; Zofran; Valtrex; Sodium Chloride; Meperidine HCL; Potassium Chloride; Leucovorin Calcium; Zofran; Sodium Chloride; Sodium Chloride; Sodium Chloride; Heparin; Leucovorin Calcium; Allopurinol; Lovenox; Morphine; Senokot; Cipro / 00042702 /; Lovenox; Prednisolone Acetate; Stomatologicals, Mouth Preparations; Tramadol; Sodium Bicarbonate



Possible Velcade side effects in 64 year old male

Reported by a physician from United States on 2012-08-16

Patient: 64 year old male, weighing 91.7 kg (201.7 pounds)

Reactions: Fungaemia, Blood Bilirubin Increased, Histiocytosis Haematophagic, Pyrexia, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Decitabine
    Dosage: 20 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-25
    End date: 2012-07-02

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-25
    End date: 2012-07-02

Other drugs received by patient: Lisinopril; Pantoprazole; Zolpidem Tartrate; Dilaudid; Metoprolol Tartrate; Cyclobenzaprine; Cefepime; Amlodipine; Atenolol; Oxycodone HCL; Sennosides A+B; Acetylsalicylic Acid SRT; Lactulose; Polyethylene Glycol; Nexium; Clopidogrel; Docusate Sodium; Furosemide; Lorazepam; Vardenafil Hydrochloride (Levitra); Acetaminophen; Calcium Carbonate; Ceftriaxone; Metoclopramide HCL / 00041902 /; Nitroglycerin; Famotidine; Flagyl; Rosuvastatin; Acyclovir; Simethicone; Dexamethasone; Vancomycin



Possible Velcade side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06

Patient: female, weighing 46.0 kg (101.2 pounds)

Reactions: Back Pain, Urinary Incontinence, Muscular Weakness, Pyrexia, Disorientation, Feeling Cold

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 32 mg, cyclic
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-01-03
    End date: 2012-03-17

Velcade
    Dosage: 1.5 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2012-03-04
    End date: 2012-03-23

Other drugs received by patient: Losartan Potassium; Omeprazole; Miralax; Reglan; Senna-S / 01035001 /; Methadone HCL; Zofran; Valtrex; Dilaudid



Possible Velcade side effects in

Reported by a physician from Romania on 2012-08-02

Patient:

Reactions: Vomiting, Amylase Increased, Nausea, Pyrexia, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Omeprazole; Vitamin B6; Dexamethasone; Allopurinol; Folic Acid



Possible Velcade side effects in

Reported by a physician from Netherlands on 2012-07-30

Patient:

Reactions: Diarrhoea, Pyrexia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1000 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-11

Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-15

Velcade
    Dosage: 2.6 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-14



Possible Velcade side effects in 78 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30

Patient: 78 year old female, weighing 46.0 kg (101.2 pounds)

Reactions: Back Pain, Urinary Incontinence, Muscular Weakness, Disorientation, Pyrexia, Feeling Cold

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 32 mg, cyclic
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-01-03
    End date: 2012-03-17

Velcade
    Dosage: 1.5 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2012-03-04
    End date: 2012-03-23

Other drugs received by patient: Zofran; Losartan Potassium; Miralax; Dilaudid; Methadone HCL; Reglan; Senna-S / 01035001 /; Omeprazole; Valtrex



Possible Velcade side effects in

Reported by a consumer/non-health professional from Japan on 2012-07-27

Patient:

Reactions: Vomiting, Amylase Increased, Platelet Count Decreased, Lipase Increased, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Januvia
    Dosage: unk
    Administration route: Oral

Velcade
    Dosage: 1.3 mg/m2, unk

Other drugs received by patient: Dexamethasone



Possible Velcade side effects in 17 year old male

Reported by a physician from United States on 2012-07-26

Patient: 17 year old male, weighing 84.1 kg (185.0 pounds)

Reactions: Hypotension, Pyrexia, Left Ventricular Dysfunction, Restrictive Cardiomyopathy, Cardiac Failure, Sepsis, Pulmonary Oedema, Acute Respiratory Distress Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 100 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-27

Cytarabine
    Dosage: 1000 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-27

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-27

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-23

Daunorubicin Hydrochloride
    Dosage: 150 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-23

Etoposide
    Dosage: 150 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-23

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-23

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-26



Possible Velcade side effects in 11 year old female

Reported by a physician from United States on 2012-07-23

Patient: 11 year old female, weighing 54.7 kg (120.3 pounds)

Reactions: Pancytopenia, Pyrexia, Caecitis, Enterocolitis Infectious

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1000 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-10
    End date: 2012-06-04

Cytarabine

Etoposide
    Dosage: 150 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-10
    End date: 2012-06-04

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-10
    End date: 2012-06-08



Possible Velcade side effects in

Reported by a physician from France on 2012-07-19

Patient:

Reactions: Lung Disorder, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 140 mg, unk
    Indication: Multiple Myeloma
    Start date: 2011-11-04
    End date: 2011-11-15

Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-11-04
    End date: 2011-11-12

Velcade
    Dosage: 2.4 mg, unk
    Indication: Multiple Myeloma
    Start date: 2011-11-04
    End date: 2012-02-07

Other drugs received by patient: Calciparine; Plavix; Lercanidipine; Ezetimibe; Perindopril Erbumine; ART; Imovane; Bisoprolol Fumarate; Pantoprazole; Klipal / 01259001 /



Possible Velcade side effects in

Reported by a physician from France on 2012-07-18

Patient:

Reactions: Respiratory Tract Infection Fungal, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: Mantle Cell Lymphoma
    Start date: 2008-11-03
    End date: 2008-11-06

Doxorubicin HCL
    Dosage: 15 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2008-11-03
    End date: 2008-11-06

Rituximab
    Dosage: 857 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2008-11-03
    End date: 2008-11-03

Velcade
    Dosage: 2 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2008-11-03
    End date: 2008-11-03



Possible Velcade side effects in

Reported by a physician from Korea, Republic of on 2012-07-17

Patient:

Reactions: Bacteraemia, Pseudomonas Infection, Epiglottitis, Neutropenia, Pyrexia, Parotitis, Blood Pressure Decreased

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Prednisolone; Melphalan Hydrochloride



Possible Velcade side effects in female

Reported by a physician from France on 2012-07-17

Patient: female, weighing 58.7 kg (129.1 pounds)

Reactions: Hypoglycaemia, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram;
    Indication: Mantle Cell Lymphoma
    Start date: 2012-06-15

Mabthera
    Indication: Mantle Cell Lymphoma
    Start date: 2012-06-14

Treanda
    Dosage: 147.6 milligram;
    Indication: Mantle Cell Lymphoma
    Start date: 2012-06-14
    End date: 2012-06-15

Velcade
    Indication: Mantle Cell Lymphoma
    Start date: 2012-06-14

Other drugs received by patient: Zolpidem; Glucophage; Potassium Chloride; Sotalol HCL; Zolpidem; Sotalol HCL; Valacyclovir Hydrochloride; Bactrim; Atorvastatin; Glimepiride; Trandolapril; Valacyclovir Hydrochloride; Bactrim



Possible Velcade side effects in

Reported by a consumer/non-health professional from United States on 2012-07-16

Patient:

Reactions: Vomiting, Dyspnoea, Nausea, Pyrexia, Cardiomyopathy, Renal Failure Chronic, Weight Increased, Tumour Lysis Syndrome, Fatigue, Respiratory Failure, Vitamin B12 Deficiency, Alopecia, Ejection Fraction Decreased, Arteriosclerosis Coronary Artery, Respiratory Tract Infection, Cardiac Failure Congestive

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma
    Start date: 2007-11-05
    End date: 2007-12-03

Other drugs received by patient: OS-CAL / 00108001 /; Colace; Nexium; Synthroid; Allopurinol; Lasix; Lisinopril; Lovenox; Aspirin



Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-16

Patient: male, weighing 86.2 kg (189.6 pounds)

Reactions: Vomiting, Nausea, Hypotension, Systemic Inflammatory Response Syndrome, Pyrexia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma
    Start date: 2012-04-17
    End date: 2012-04-24

Velcade
    Dosage: 2.3 mg, unk
    Start date: 2012-05-04



Possible Velcade side effects in female

Reported by a physician from France on 2012-07-12

Patient: female, weighing 58.7 kg (129.1 pounds)

Reactions: Hypoglycaemia, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Indication: Mantle Cell Lymphoma

Rituxan
    Indication: Mantle Cell Lymphoma

Treanda
    Indication: Mantle Cell Lymphoma

Velcade
    Indication: Mantle Cell Lymphoma



Possible Velcade side effects in

Reported by a physician from Netherlands on 2012-07-12

Patient:

Reactions: Diarrhoea, Pyrexia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1000 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-11

Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-15

Velcade
    Dosage: 2.6 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-14



Possible Velcade side effects in

Reported by a physician from United Kingdom on 2012-07-10

Patient:

Reactions: Off Label Use, Dyspnoea, Hypotension, Chest Pain, Pleural Effusion, Troponin Increased, Pyrexia, Myocardial Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Bendroflumethiazide; Codeine Sulfate; Dexamethasone; Gabapentin; Ibuprofen; Bisacodyl; Acetaminophen; Pamidronate Disodium; Amitriptyline HCL; Diazepam; Enoxaparin; Tramadol HCL



Possible Velcade side effects in

Reported by a physician from Korea, Republic of on 2012-07-10

Patient:

Reactions: Bacteraemia, Pseudomonas Infection, Epiglottitis, Pyrexia, Neutropenia, Parotitis

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Prednisolone; Melphalan Hydrochloride



Possible Velcade side effects in 17 year old male

Reported by a physician from United States on 2012-07-09

Patient: 17 year old male, weighing 84.1 kg (185.0 pounds)

Reactions: Hypotension, Pyrexia, Left Ventricular Dysfunction, Restrictive Cardiomyopathy, Cardiac Failure, Sepsis, Acute Respiratory Distress Syndrome, Pulmonary Oedema

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-27

Cytarabine
    Dosage: 100 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-27

Cytarabine
    Dosage: 1000 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-27

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-23

Daunorubicin Hydrochloride
    Dosage: 150 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-23

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-23

Etoposide
    Dosage: 150 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-23

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-26



Possible Velcade side effects in

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-09

Patient:

Reactions: Pyrexia, Lethargy, Cough, Cerebral Haemorrhage

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-12-25
    End date: 2012-02-09

Doxorubicin HCL
    Dosage: 66 mg, unk
    Indication: Multiple Myeloma
    Start date: 2011-12-25
    End date: 2012-02-02

Velcade
    Dosage: 2.4 mg, unk
    Indication: Multiple Myeloma
    Start date: 2011-12-25
    End date: 2012-02-09



Possible Velcade side effects in

Reported by a physician from France on 2012-07-09

Patient:

Reactions: Lung Disorder, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 140 mg, unk
    Indication: Multiple Myeloma
    Start date: 2011-11-04
    End date: 2011-11-15

Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-11-04
    End date: 2011-11-12

Velcade
    Dosage: 2.4 mg, unk
    Indication: Multiple Myeloma
    Start date: 2011-11-04
    End date: 2012-02-07

Other drugs received by patient: Calciparine; Pantoprazole; Bisoprolol Fumarate; Plavix; Lercanidipine; Perindopril Erbumine; Ezetimibe; Klipal / 01259001 /; ART; Imovane



Possible Velcade side effects in

Reported by a pharmacist from Netherlands on 2012-07-06

Patient:

Reactions: Diarrhoea, Oliguria, Colitis, Pyrexia, Thrombocytopenia, Leukopenia, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Valaciclovir; Cyclophosphamide; Fluconazole; Cotrim; Dexamethasone



Possible Velcade side effects in

Reported by a physician from Japan on 2012-07-05

Patient:

Reactions: Myocardial Haemorrhage, Shock Haemorrhagic, Pyrexia, Off Label Use, Lung Disorder, Cerebral Infarction, Duodenal Ulcer Haemorrhage, Ventricular Fibrillation, Cardiac Arrest

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
    Dosage: unk
    Indication: Leukaemia Plasmacytic
    Start date: 2012-04-17
    End date: 2012-05-13

Velcade
    Dosage: 1.3 mg, unk
    Indication: Leukaemia Plasmacytic
    Start date: 2012-04-20
    End date: 2012-04-30

Other drugs received by patient: Lactulose; Rebamipide



Possible Velcade side effects in

Reported by a physician from Japan on 2012-07-05

Patient:

Reactions: Shock Haemorrhagic, Myocardial Haemorrhage, Pyrexia, Off Label Use, Lung Disorder, Cerebral Infarction, Duodenal Ulcer Haemorrhage, Ventricular Fibrillation, Cardiac Arrest

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
    Dosage: unk
    Indication: Leukaemia Plasmacytic
    Start date: 2012-04-17
    End date: 2012-05-13

Velcade
    Dosage: 1.3 mg, unk
    Indication: Leukaemia Plasmacytic
    Start date: 2012-04-20
    End date: 2012-04-30

Other drugs received by patient: Lactulose; Rebamipide



Possible Velcade side effects in

Reported by a physician from Romania on 2012-07-05

Patient:

Reactions: Amylase Increased, Vomiting, Nausea, Pyrexia, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Omeprazole; Allopurinol; Dexamethasone Sodium Phosphate; Folic Acid; Vitamin B6



Possible Velcade side effects in

Reported by a physician from France on 2012-06-29

Patient:

Reactions: Death, Lung Disorder, Pyrexia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 140 mg, unk
    Indication: Multiple Myeloma
    Start date: 2011-11-04
    End date: 2011-11-15

Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-11-04
    End date: 2011-11-12

Velcade
    Dosage: 2.4 mg, unk
    Indication: Multiple Myeloma
    Start date: 2011-11-04
    End date: 2012-02-07

Other drugs received by patient: ART; Calciparine; Pantoprazole; Imovane; Bisoprolol Fumarate; Plavix; Ezetimibe; Perindopril Erbumine; Lercanidipine; Klipal / 01259001 /



Possible Velcade side effects in

Reported by a physician from Netherlands on 2012-06-29

Patient:

Reactions: Chest Pain, Oropharyngeal Pain, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Neupogen
    Indication: Multiple Myeloma

Velcade
    Indication: Multiple Myeloma

Other drugs received by patient: Acetaminophen; Fentanyl Citrate; Neupogen; Morphine Sulfate; Gabapentin; Acenocoumarol; Valaciclovir



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017